Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|REGN||Regeneron Pharmaceuticals, Inc.||-1.33%||594.42||2.6%||$512.04m|
|GILD||Gilead Sciences, Inc.||-0.99%||62.21||1.0%||$507.75m|
|VRTX||Vertex Pharmaceuticals, Inc.||-3.88%||276.17||1.9%||$501.77m|
|SNSS||Sunesis Pharmaceuticals, Inc.||2.77%||3.34||0.7%||$233.48m|
|CRSP||CRISPR Therapeutics AG||-5.41%||63.28||0.6%||$169.89m|
|BMRN||BioMarin Pharmaceutical, Inc.||-2.28%||83.15||4.2%||$123.51m|
|EXAS||EXACT Sciences Corp.||-6.78%||41.11||17.7%||$99.49m|
|IOVA||Iovance Biotherapeutics, Inc.||-1.35%||10.98||0.0%||$95.65m|
Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing novel immunotherapies for the treatment of cancer. Its pipeline APVO436, ALG.APV-527 and APVO603 were developed based on the ADAPTIR modular protein platform technology and APVO442 was developed based on the new ADAPTIR-FLE platform technology. The ADAPTIR and ADAPTIR-FLEX are capable of generating differentiated bispecific and multi-specific antibodies with potentially unique mechanisms of action for the treatment of different types of cancer. The company was founded on February 22, 2016 and is headquartered in Seattle, WA.